We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RIFM Adopts BlueScreen HC™ for Early Genetic Toxicology Screening of Fragrance Materials

News   Jun 19, 2013

 
RIFM Adopts BlueScreen HC™ for Early Genetic Toxicology Screening of Fragrance Materials
 
 
 

RELATED ARTICLES

Human Blood-Brain Barrier Chip Aids Development of Brain-targeting Drugs

News

A microfluidic organ chip model of the human blood-brain barrier, that recapitulates in vivo barrier functions, offers a new preclinical tool for development of brain-targeting therapeutics.

READ MORE

Epilepsy Drugs Linked to Increased Risk of Suicidal Behavior, Study Finds

News

Treatment with a group of drugs used for epilepsy, nerve pain and anxiety disorders – called gabapentinoids – is associated with an increased risk of suicidal behavior, unintentional overdose, injuries, and road traffic incidents, according to a new study published in BMJ.

READ MORE

Immunotherapy and Diabetes – A Step Towards Understanding the Link

News

Immune checkpoint inhibitors (ICIs) are an emerging type of cancer immunotherapy that uses the immune system to attack cancer cells. However, in some patients they cause the immune system to attack healthy cells – when pancreatic beta cells are attacked, this can lead to type 1 diabetes.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE